Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 05, 2015 11:28 AM ET

Life Sciences Tools and Services

Company Overview of ForteBio, Inc.

Company Overview

ForteBio, Inc. develops analytical systems to accelerate biotherapeutic drug discovery and development for biopharmaceutical companies worldwide. The company offers Octet System, a platform that includes instruments, biosensors, reagents, and assay kits for the analysis of biomolecular interactions in 96- and 384-well microplates; BLItz System, a personal protein analysis system for individual researchers; biosensors and assay kits; and anti-Chinese hamster ovary host cell proteins detection kits. Its systems enable real-time, label-free analysis of biomolecular interactions, providing information on affinity, kinetics, and concentration; and allow scientists in life science, pharmaceutical,...

Menlo Science & Technology Park

1360 Willow Road

Suite 201

Menlo Park, CA 94025

United States

Founded in 2001





Key Executives for ForteBio, Inc.

Chief Executive Officer, President and Director
Age: 62
Vice President of Product Development & Operations and General Manager
Age: 45
Vice President of China Operations
Executive Officer
Age: 56
Vice President of Marketing
Compensation as of Fiscal Year 2015.

ForteBio, Inc. Key Developments

Pall ForteBio LLC Launches Octet K2 System

Pall ForteBio LLC announced the launch of the Octet K2 system, a new entry point into the Octet line of label-free interaction analysis systems. Available in Asia and Europe, the Octet K2 system offers high-performance, budget-friendly kinetic characterization of antibody, protein, and small molecule binding interactions. Using Pall ForteBio’s Bio-Layer Interferometry (BLI) technology, the systems in the Octet family offer a fluidics-free alternative to surface plasmon resonance (SPR) with a variety of off-the-shelf Dip and Read™ biosensors for more rapid assay development and optimization. The Octet K2 system increases accessibility to BLI in a low-throughput, 2-channel instrument that provides exquisite binding affinity data, even for molecules down to 150 daltons in size.

Similar Private Companies By Industry

Company Name Region
Investigen, Inc. United States
SNBL U.S.A. Ltd. United States
GeneSeek Inc. United States
Sciformix Corporation United States
Clinilabs, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ForteBio, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at